Oncolytics Biotech Inc.
Oncolytics Biotech, Inc. announces publication of research
Published in Biotech Business Week, January 21st, 2008
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) (‘Oncolytics’) reported that a research group led by Dr. Richard Vile of the Mayo Clinic College of Medicine in Rochester, Minnesota, published the results of its work testing the antitumor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo. The paper, entitled "Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus" appears online in the January 1, 2008 issue of Clinical Cancer Research.
"This exciting Mayo Clinic work supported the initiation of our combination REOLYSIN® and cyclophosphamide clinical trial, recently...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Breast Cancer
Docetaxel given after doxorubicin reduces recurrence - Clinical Trial Research
New statistical technique shows more informative picture of survival - Medicare and Medicaid
Despite efforts, significant racial disparities in cancer therapy still exist - Medicare and Medicaid
Racial disparities persist in cancer care - Obesity and Diabetes
Diabetes medication and lifestyle changes can help treat weight gain induced by antipsychotic drugs - Tissue Engineering
Freeze-dried tendon implants prove effective in early studies - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
